Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05972252
Status:
RECRUITING
Last Update Posted:
2023-10-18
First Post:
2023-07-25
Brief Title:
First-in-man Study of the Cerebrovascular Interventional Procedural Control System
Sponsor:
Hangzhou Dinova Neuroscience Technology Co Ltd
Organization:
Hangzhou Dinova Neuroscience Technology Co Ltd
Study Overview
Official Title:
A Feasibility Study to Evaluate the Safety and Efficacy of the Cerebrovascular Interventional Procedural Control System in Treatment of Acute Ischemic Stroke
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study the first human use of a new device in treatment of acute ischemic stroke which to evaluate the feasibility safety and efficacy of the Cerebrovascular Interventional Procedural Control System
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None